Frequently Asked Questions
Common Questions About Using ICD-10 Code D05.81 for Other specified type of carcinoma in situ of right breast
What are the treatment options for carcinoma in situ?
Treatment options for carcinoma in situ typically include surgical intervention, such as lumpectomy or mastectomy, and may involve radiation therapy to reduce the risk of recurrence. Regular follow-up is essential for monitoring.
How is carcinoma in situ diagnosed?
Carcinoma in situ is diagnosed through imaging studies, such as mammograms, followed by biopsy to confirm the presence of abnormal cells. Clinical examination and patient history also play a crucial role.
Is carcinoma in situ considered cancer?
Yes, carcinoma in situ is classified as a non-invasive form of cancer. While it does not spread beyond the ducts or lobules, it requires treatment to prevent progression to invasive cancer.
What is the prognosis for carcinoma in situ?
The prognosis for carcinoma in situ is generally favorable, especially with early detection and appropriate treatment. Regular monitoring is essential to ensure no progression to invasive disease.
